Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock-based Compensation Expense (Details)

v3.23.1
Schedule of Stock-based Compensation Expense (Details) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 341,504 $ 828,897
Research and Development Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 99,621 191,875
General and Administrative Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 241,883 $ 637,022